The valosin-containing protein promotes cardiac survival through the inducible isoform of nitric oxide synthase
Open Access
- 4 June 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 99 (4), 685-693
- https://doi.org/10.1093/cvr/cvt136
Abstract
Expression of the heat shock protein 22 (Hsp22) in the heart stimulates cardiac cell survival through activation of the Akt pathway and expression of the inducible nitric oxide (NO) synthase (iNOS), the mediator of ischaemic preconditioning and the most powerful prophylaxis against cardiac cell death. The goal of the present study was to elucidate the downstream effector by which Hsp22 and Akt increase iNOS expression. We tested both in vivo and in vitro the hypothesis that such an effector is the valosin-containing protein (VCP), an Akt substrate, which activates the transcription factor NF-κB, using a transgenic mouse with cardiac-specific over-expression of Hsp22, as well as isolated rat cardiac myocytes. Using two-dimensional gel electrophoresis and mass spectrometry combined with immunoprecipitation, we found that Hsp22 and Akt co-localize and interact together with VCP. Adeno-mediated over-expression of VCP in isolated cardiac myocytes activated NF-κB and dose-dependently increased the expression of iNOS, which was abolished upon NF-κB inhibition. Over-expression of a dominant-negative (DN) mutant of VCP did not increase iNOS expression. VCP, but not its DN mutant, protected against chelerythrine-induced apoptosis, which was suppressed by inhibition of either NF-κB or iNOS. VCP-mediated activation of the NF-κB/iNOS pathway was also prevented upon inhibition of Akt. We conclude that the Akt substrate, VCP, mediates the increased expression of iNOS downstream from Hsp22 through an NF-κB-dependent mechanism.This publication has 24 references indexed in Scilit:
- H11 Kinase/Heat Shock Protein 22 Deletion Impairs Both Nuclear and Mitochondrial Functions of STAT3 and Accelerates the Transition Into Heart Failure on Cardiac OverloadCirculation, 2011
- Regulation of the expression of inducible nitric oxide synthaseEuropean Journal of Pharmacology, 2004
- Signaling to NF-κBGenes & Development, 2004
- Program of Cell Survival Underlying Human and Experimental Hibernating MyocardiumCirculation Research, 2004
- RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysisJournal of Cell Science, 2004
- Functional ATPase Activity of p97/Valosin-containing Protein (VCP) Is Required for the Quality Control of Endoplasmic Reticulum in Neuronally Differentiated Mammalian PC12 CellsPublished by Elsevier BV ,2002
- H11 Kinase Is a Novel Mediator of Myocardial Hypertrophy In VivoCirculation Research, 2002
- VCP (p97) Regulates NFKB Signaling Pathway, Which Is Important for Metastasis of Osteosarcoma Cell LineJapanese Journal of Cancer Research, 2002
- Cardioprotective Function of Inducible Nitric Oxide Synthase and Role of Nitric Oxide in Myocardial Ischemia and Preconditioning: an Overview of a Decade of ResearchJournal of Molecular and Cellular Cardiology, 2001
- Gene program for cardiac cell survival induced by transient ischemia in conscious pigsProceedings of the National Academy of Sciences of the United States of America, 2001